Etiologically oriented treatment and the
role of the Swedish industry
 Developing
improved neuroleptics
The pharmaceutical industry has a history of success in developing
improved neuroleptics for the treatment of schizophrenia, these
substances being especially efficient in controlling hallucinations
and delusions.
Still, available treatments are far from
optimal
Nevertheless, the treatments available today are generally far from
optimal. They have not succeeded in eradicating the debilitating
effects of the disease on the patients´ motivation, general
functioning in society or quality of life in total. A major reason
for this lack of optimization is that treatment is symptomatic rather
than etiologically based.
Development of treatment systems for mental
disorders
An important goal for the research within the HUBIN consortium is
the development of etiologically oriented treatment systems for
schizophrenia and other mental disorders.
|
